Status:

COMPLETED

Intraperitoneal Aerosol Chemotherapy in Gastric Cancer

Lead Sponsor:

Ruhr University of Bochum

Conditions:

Gastric Cancer

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

A prospective series of patients with recurrent gastric cancer will be treated with three cycles of chemotherapy (doxorubicin and cisplatin) instilled into the abdominal cavity in the form of an aeros...

Detailed Description

Objectives: To evaluate the safety and efficacy in terms of the clinical benefit rate (CBR) of PIPAC in peritoneal carcinomatosis (PC) from gastric cancer (GC) Study design: Single center, open label,...

Eligibility Criteria

Inclusion

  • age above 18 years
  • written, informed consent
  • presence of peritoneal carcinomatosis

Exclusion

  • language barrier
  • parenchymal metastases
  • unability to undergo laparoscopy

Key Trial Info

Start Date :

November 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2016

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT01854255

Start Date

November 1 2013

End Date

November 1 2016

Last Update

July 8 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ruhr University of Bochum

Herne, North Rhine-Westphalia, Germany, 44625